Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RGNX

Regenxbio Inc

May 22 • 04:00PM ET

6.35

-0.40 -5.93 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NGNE FDMT QURE STOK EDIT

| Held by: VTI XBI IWM VXF IWN IBB VTWO FESM KOMP SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-5.59	Insider Own	9.34%	Shs Outstand	51.62M	Perf Week	11.01%
Market Cap	328.28M	Forward P/E	-	EPS next Y	-2.92	Insider Trans	-0.42%	Shs Float	46.87M	Perf Month	-29.37%
Enterprise Value	426.19M	PEG	-	EPS next Q	0.25	Inst Own	81.16%	Short Float	14.28%	Perf Quarter	-20.03%
Income	-290.01M	P/S	3.74	EPS this Y	24.27%	Inst Trans	3.47%	Short Ratio	5.89	Perf Half Y	-41.90%
Sales	87.82M	P/B	15.55	EPS next Y	-2.52%	ROA	-69.65%	Short Interest	6.69M	Perf YTD	-55.90%
Book/sh	0.41	P/C	2.18	EPS next 5Y	28.01%	ROE	-196.43%	52W High	16.19 -60.78%	Perf Year	-35.60%
Cash/sh	2.91	P/FCF	-	EPS past 3/5Y	16.67% -4.73%	ROIC	-117.23%	52W Low	5.45 16.41%	Perf 3Y	-69.07%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	14.78% 1.97%	Gross Margin	50.52%	Volatility	9.14% 9.11%	Perf 5Y	-81.92%
Dividend TTM	-	EV/Sales	4.85	EPS Y/Y TTM	-78.31%	Oper. Margin	-292.28%	ATR (14)	0.77	Perf 10Y	-47.30%
Dividend Ex-Date	-	Quick Ratio	2.62	Sales Y/Y TTM	-43.96%	Profit Margin	-330.23%	RSI (14)	35.97	Recom	1.42
Dividend Gr. 3/5Y	- -	Current Ratio	2.62	EPS Q/Q	-1551.90%	SMA20	-23.63%	Beta	1.07	Target Price	25.92
Payout	-	Debt/Eq	11.78	Sales Q/Q	-92.82%	SMA50	-25.66%	Rel Volume	1.38	Prev Close	6.75
Employees	371	LT Debt/Eq	10.74	Earnings	May 14 BMO	SMA200	-39.54%	Avg Volume	1.14M	Price	6.35
IPO	Sep 17, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-28.65% -75.26%	Trades		Volume	1,569,482	Change	-5.93%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)